NuVasive Extends Spine Innovator Leadership Position,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
NuVasive Extends Spine Innovator Leadership Position, Launches New Solutions at 84th AANS Annual Scientific Meeting

SAN DIEGO, CA --(Marketwired - April 28, 2016) - NuVasive, Inc. ( NASDAQ : NUVA ), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will launch five new surgical solutions at the 84 th American Association of Neurological Surgeons (AANS) Annual Scientific Meeting, being held April 30 - May 4, 2016 in Chicago, IL.

Supporting NuVasive's commitment to transforming and advancing spine surgery, the Company will showcase its industry-leading innovation through the introduction of new technologies to address the latest advancement in lumbar and cervical spine surgery. Additionally, the Company continues to support surgeon education through numerous education workshops, with demonstrations of its Integrated Global Alignment (iGA™) system, as well as practical clinics highlighting the advantages of minimally-invasive techniques and ongoing surgeon support and adoption.

Pat Miles, President and Chief Operating Officer of NuVasive, commented, "Our latest solutions reinforce NuVasive's continued commitment to industry-leading innovation that clearly demonstrates the clinical and economic value of our procedurally-integrated offerings for spine. We are laser-focused on providing surgeons and health systems products designed to provide the best possible patient outcomes."

NuVasive AANS Participation Details

The Company will showcase and have available for demonstrations its new technologies at NuVasive Booth #4627 on the AANS exhibit floor, including:

  • AttraX® Putty Biotextured™ Bone Graft:  AttraX Putty is a next generation, synthetic biologic product indicated for use as an autograft extender in posterior lateral spine applications. Its unique Biotextured surface technology promotes bone formation and its unique formulation provides excellent handling characteristics.
  • Reline® Modular System and Reline Power: Reline Modular (MOD) is designed to improve visualization and access to the intervertebral disc for fusion work in TLIF and PLIF procedures, while providing expanded decortication and superior distraction. This modular-based, pedicle screw system includes unique modular tulip designs that provide for versatile implant options. Reline Power expedites screw placement with its integrated power delivery system, ergonomically designed for surgeons.
  • MAS® TLIF 2:  MAS TLIF 2 is the next generation of NuVasive's minimally-invasive, pedicle-based approach to provide efficient, reproducible and step-by-step technique for TLIF procedures. This updated system includes a re-designed retractor for improved visibility and functionality, an innovative screw shank attachment that is simple and secure, as well as advanced interbody and graft delivery solutions. 
  • Monolith™ Corpectomy System: Monolith is a fully modular, imaging-friendly PEEK implant indicated for use T1-L5 with supplemental fixation. The system features multiple core, endcap and angulation options, which provide surgeons versatility in the OR.

NuVasive's exhibit booth will include additional products and procedures, featuring an enhanced interactive experience highlighting iGA's proprietary, procedurally-integrated, digital platform of specialized products designed to help surgeons achieve more precise spinal column alignment. Additionally, the booth will highlight the recently added MAGnetic External Control, or MAGEC®, early-onset scoliosis spinal bracing and distraction system.

NuVasive will host a series of workshops and practical clinics at AANS 2016. Visit the Company's website for a downloadable list.

About NuVasive

NuVasive is a global medical device company focused on transforming spine surgery by empowering surgeons with technology to approach procedures in the least disruptive way possible and restore the vitality of life for those that suffer from debilitating spinal conditions. Through its minimally invasive, procedurally-integrated solutions, the Company is expanding the boundaries of modern healthcare with technologies and surgeon training designed to provide reproducible and clinically-proven surgical outcomes that are redefining the success factors of spine surgery like never before. Addressing a variety of pathologies up and down the spine, from complex spinal deformity to degenerative spinal conditions, NuVasive's highly differentiated solutions include access instruments, implantable hardware and increasingly expert software systems like its game-changing iGA™ surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. NuVasive believes its integrated approach and expertise can fundamentally evolve spine care by delivering improved patient experiences, and better economics healthcare systems. With $811 million in revenues as of the end of 2015, NuVasive has an approximate 1,600 person workforce in more than 40 countries around the world. For more information on the Company, please visit www.nuvasive.com .

NuVasive   cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause   NuVasive's   results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of   NuVasive's products (including the iGA™ platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in   NuVasive's   news releases and periodic filings with the   Securities and Exchange Commission.   NuVasive's public filings with the   Securities and Exchange Commission   are available at   www.sec.gov .   NuVasive   assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

Media Contact: Michael Farrington NuVasive, Inc. 858-909-1940 media@nuvasive.com Investor Contact: Stacy Roughan NuVasive, Inc. 858-909-1812 investorrelations@nuvasive.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 16

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 150

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
CSMI Boosts CT's Cybersecurity for Defense Sector

Updated Category News Views 132

Paving the Way for Cybersecurity Excellence Out in chilly Connecticut, CSMI made a mark. The State's Office of Manufacturing picked them to join the advisory council for the Defense CyberSecure Program (CT-DCP). It ain’t just a pat on the back; it's a big deal for the region's defense and aerospace manufacturing gang. Connecticut's got its eyes set on beefing up its...

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 127

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
NVCA Refreshes Key Venture Legal Documents for 2026

Updated Category News Views 115

Keeping Pace with Evolving Venture Norms Change never lets up in the fast-paced world of venture capital, does it? Just when you think you've got the rules figured out, the game shifts. This time, it's the National Venture Capital Association (NVCA) shaking things up. They've given a facelift to seven of their model legal documents, a move that reshapes the legal...

Continue Reading
GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 91

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window

Updated Category News Views 28

A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...

Continue Reading
Stellus PBDC's Q3: Solid Income but NAV Drops

Updated Category News Views 208

Stellus PBDC: Q3 Earnings and Strategic Moves Things are getting interesting in Houston where Stellus Private Credit BDC just laid out its financial cards for the third quarter of 2026. Now, I’ve seen my fair share of quarterly reports, but Stellus seems to have stitched a quilt of mixed results this time around. Investment Income and Portfolio Shifts First off, net...

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 213

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
Fuel Cell Market Faces Uneven Growth Amid Revenue Shifts

Updated Category News Views 144

Fuel Cell Sector Eyes Mixed Results and Big Projections The fuel cell market, oh what a beast it's becoming—a story filled with ups and downs, and more forecasts than a weather station. As we stand, this sector is poised to balloon to an $18.16 billion market by 2030. That's a growth rate of 26.3% annually, folks. These projections are driving excitement, but the...

Continue Reading

Top 5 Most Recently Viewed Articles

PHX Minerals Set to Release Full-Year 2024 Financial Results

Updated Category News Views 176

PHX Minerals Reveals Upcoming Financial Results Announcement PHX MINERALS INC., commonly known as PHX, is preparing to share its financial results for the year that concluded on December 31, 2024. This announcement is eagerly awaited by investors and stakeholders, marking a significant moment in understanding the company’s financial health and future outlook. Details of...

Continue Reading
Baird Optimistic on First Industrial Realty Trust Growth Ahead

Updated Category News Views 183

Baird's Positive Outlook for First Industrial Realty Trust Baird has reaffirmed its positive stance on First Industrial Realty Trust (NYSE: FR), maintaining an Outperform rating alongside a $61.00 price target. The firm's analysis indicates that the company's core portfolio is projected to deliver a stable 6% annual growth, signaling strong performance prospects for...

Continue Reading
Aprea Therapeutics Secures $3.1 Million Investment for Growth

Updated Category News Views 151

Aprea Therapeutics Secures $3.1 Million Investment Aprea Therapeutics, Inc. (Nasdaq: APRE), a forward-thinking clinical-stage biopharmaceutical company, has announced a notable private placement aimed at enhancing its development of innovative cancer treatments. This financing comes from a blend of new and existing investors, reflecting confidence in the company’s...

Continue Reading
Silal and SVG Forge New Paths in Sustainable Agriculture

Updated Category News Views 174

Silal and SVG Forge New Paths in Sustainable Agriculture In a significant development for the agricultural sector, Silal, a leading agri-food and technology company, and Shouguang Colorful Manor Modern Agriculture Co., Ltd (SVG) have entered a joint venture that stands to revolutionize sustainable agriculture practices. This landmark agreement was witnessed by eminent...

Continue Reading